Home About Us | Members | Register | Brochure | Events  | Management CenterContact Us ÖÐÎİæ
 Registration
  Registration
  Price & Payment
  Hotel Info
  Tech Tour
  For Accompanies
  Food Preferences
 WCV 2008
  General Information
  Past Event Report
  Organizers & SAB
  Agenda
  Scientific Program
  Track Info
  Key Dates
  About the Venue
  Online Broadcasting Tool
 For Speakers
  Why Speak?
  Oral Presentations
  Abstracts & Biography
 For Exhibitors
  Exhibitors
  Media Partners
  Posters
  Job Posting
 For Sponsors
  Who Should Sponsor?
  Sponsorship Options
 For Attendees
  Group Participants
  Individuals
  Invitation and Visa
 Business Development
  Innovators
  Investors
  Market Expansion
  Advertisement
  Outsourcing
 Tech Tour
  Guilin Guide
  Social Event
  Transportation
  Weather
  Photo Gallery
 Additional Information
  Call for Co-Organizers
  Help & FQA
  Send Feedback
  BIT's conferences - 2008
PepCon-2008
(April 22-24, 2009, Shenzhen, China)
ibio-2008
(May 18-22, 2008, Hangzhou, China)
WCC-2008
(June 12-17, 2008, Shanghai, China)
WSA-2008
(July 20-26, 2008, Kunming, China)
Bio-VC 2008
(Oct. 11-13, 2008, Dalian, China)
IDDST 2008
(Oct.18-22, 2008, Beijing, China )
CEMD-2008
(Oct.22-28, 2008, Beijing & Xi'an, China)
RMSC 2008
(Dec.2-4, 2008, Foshan, China)
WCG 2008
(Dec.5-7, 2008, FoShan, China)
 

As the keynote speakers, Dr. John B Robbins, Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA; Dr. Michael Favorov, Director General, International Vaccine Institute (IVI), Korea; Dr. Katherine Cohen, VP, Corporate & Business Development, Intercell AG, Austria;made excellent presentations and warmly discussed with the audiences at keynote forum.


To Schedule more than 300 Scientific/Tech and Business/Economics/Policy Presentations on frontier of vaccinology and vaccine development from world class scientists, executives and decision makers
To Call for 50 poster demonstration and 50 expositions of new products and technologies to expand visibilities to the up to 500-800 targeted audiences
To Arrange round table network for business and market development
To Foster friendship through a Warm Tour in the holly season to the ever-spring regions in southern China
The BIT's 1st Annual World Congress of Vaccine provides highquality and current reports of scientific progress featured in calling for presentations and submitted abstracts presenting at Six Remarkable Tracks, which cover a broad spectrum of current status of Vaccine development in not only human vaccination fields, but also to extend to Livestock, Agricultural and Aquaculture Vaccine R & D and business development. The disparate fields covered in both human and veterinary vaccinology encourage valuable cross-fertilization of ideas and approaches among researchers otherwise focused on specific diseases or methods.

The Congress will be the largest meeting devoted exclusively to the research on vaccines and associated technologies for disease prevention and treatment. Both of international and domestic experts will lead sessions and panel discussions on topical areas of basic science, product development, clinical testing, regulation, and other aspects of vaccine research. Opportunities for networking and scientific collaboration critical to advancing vaccine science and development will be available through audience discussions, poster presentations, sponsored exhibits, and evening ceremonies and receptions.

The Eight Remarkable Program Tracks cover a broad spectrum of current status of Vaccine development in not only human vaccination fields, but also to extend to Livestock, Agricultural and aquaculture Vaccine R & D and business development.

Track: 1 Public Health, Economics, Safety/ Ethic and Policy of Vaccination
- How to Turn the Gift of Vaccinations into Being Best Applied to Mankind
Track: 2 Scientific & Technological Frontiers of Vaccines
- Knowledge Empowers Vaccine Discovery
Track: 3 Human Preventive and Therapeutic Vaccines-Future Vaccines
- Fueling Your Pipelines for the Future Vaccines
Track: 4 Other Human Vaccine Development
- Control Bad Influences and Protect Homeland Security

Track: 5 Vaccine R & D for Emerging Infectious Diseases
- New Vaccine Avenue to Life Threatening Epidemic Diseases
Track: 6 Livestock/Veterinary/ Aquaculture Vaccine R & D
- Defense Our Nature Resources and Ourselves from Diseases
Track: 7 Vaccine Production Tech and Manufacturing Strategies
- Ride on the 4th Wave of White Biotechnology
Track: 8 International Business & Market Development
- Integration of Global Resources for Sustainable Success


Presentations-Find the answers you need

Exhibition-Showcase and Exposure to professionals

Sessions-Get first-hand information

Partnering-Generate new collaboration
The key at the conclusion of this conference, participants should be able to meet the following conference objectives:
To provide a progressive state-of-the-art report so that researchers and other workers in the field can advance and progress the field knowing what is already available
To accelerate progress in the development of vaccines to infectious and non-infectious diseases that threaten the well-being of citizens
To encourage a prophylactic approach to healthcare and discover its boundaries
To discuss recent scientific advances that are contributing to progress in the development of vaccines
To identify research opportunities and scientific challenges associated with vaccine development, production and distribution
The Congress will serve as an interface to bring together researchers, clinicians, epidemiologists, Microbiologists, Immunologists, Molecular Biologists, public health officials, representatives from the pharmaceutical / biotechnology industry, and policy makers from around the world.
Dr. John B Robbins
Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA
Dr. John D. Clemens Director General, International Vaccine Institute (IVI), Korea
Dr. Alan Shaw
Chief Executive Officer, Vaxinnate Corporation, USA
Dr. Peter Khoury
Vice President, Global Marketing Baxter Bioscience-Vaccines, USA
Dr. Francis E. Andr¨¦
Ex-Vice President, GlaxoSmithKline Biologicals, Belgium
Dr. Jaap Goudsmit
Chief Scientific Officer, Crucell, Netherlands
Dr. Katherine Cohen
Vice President, Corporate & Business Development, Intercell AG, Austria

Dr.Alexander K. Andrianov
Vice President, Apogee Technology, Inc. USA

Dr. Kelly Lyn Warfield
Vice President of Vaccine Development
Integrated BioTherapeutics Inc.
Dr. JAMES J. JAMES
Director, AMA Center for Public Health Preparedness and Disaster Response, USA
Dr. Xiaofeng Liang
Director, Chinese CDC & Prevention, National Immunisation Programme, China
Dr. Luc Aujame
Director, External R&D, Sanofi Pasteur, France
Dr. Jonathan Liu
Director, Research and Development MedImmune, LLC., AstraZeneca, USA
Dr. Ralf Kircheis
CSO/Founder, Vela pharm. Entwicklung u. Laboranalytik GmbH, Austria
BIT's 1st Annual World Congress of Vaccine looks forward to welcoming you to Foshan for a stimulating scientific program and secure your position in the industry and reach highly qualified prospects for your products and solutions.
Be an WCV 2008 Sponsor Now!

International Vaccine Institute
International AIDS Vaccine Institute
Global TB Vaccine Foundation
Center for Disease Control and Prevention, China
Center for Disease Control and Prevention, USA
Sabin Vaccine Institute, USA
National Institutes of Health , USA
National Human Genome Research, USA
Novartis AG, Switzerland
Merck, USA
Sanofi Pasteur, France
MedImmune, USA
Wyeth, USA
GlaxoSmithKline Biologicals, Belgium
Pfizer, USA
ASTRAZENECA, USA
IOMAI, USA
Baxter, USA
Novozymes A/S, Denmark
Intercell, Austria
Crucell, Netherlands
Apogee Technology, Inc, USA
Acambis, UK
Chiron, USA
VaxGen, USA
Vaxinnate, USA
VaxGen, USA
ViRexx, Canada
Apthera, USA
Maxygen, USA
Virionics, USA
CSC, USA
3M, USA
OptiNose AS, Norway
Civimetrix, Canada
Apotex, Canada
AccuDx, USA
Sigma-Aldrich, USA
Vaxine, Australia
OsteoMed II, USA
CNAPS Medical Devices, Canada
Iman I Mass Awareness Network, Canada
Apotex, Canada
Toxi-Health, USA
Apthera, USA
Bioniche Animal Health, Canada
Ceva-Phylaxia Zrt, Hungary
Biovet Pvt Ltd, India
Egafish Systems, Israel
Integrated BioTherapeutics,USA
Aquatic Diagnostics, UK
Synergy America, USA
Virionics Corporation, USA
immatics biotechnologies GmbH,Germany
Green Hills Biotechnology GmbH, Austria
Gan Shmuel, Israel.
SIOGEN Biotech, Malaysia
University of Cambridge, UK
Medical University of Vienna, Austria
University of Mississippi Medical Center, USA
Utah State University, USA
University of Louvain, Belgium
University of Florida, USA
Oxford University, UK
University of Uberlandia, Brazil
Johns Hopkins University School of Medicine, USA
University of Strasbourg, French
Emory University, USA
University of Glasgow, UK
University of Leicester, UK
Stanford University, USA
University of Minnesota, USA
University of Pennsylvania, USA
University of Pittsburgh, USA
University of Linkoping, Sweden
University of New South Wales, Australia
Colorado State University, USA
University of Tampere, Finland
University of Vienna Waehringer, Austria
University of Quindio, Colombia
Arizona State University, USA
University of California, USA
Seoul National University, Korea
University of Queensland, Australia
University of Washington, USA
University of Ottawa, Canada

China Medicinal Biotech Association

People's Government of Foshan, China
People' s Government of Sanshui District, China

Science & Technology Bureau of Foshan City, China

Dalian BIT Life Sciences, Inc., China
Science & Technology Bureau of Foshan Sanshui District, China

The Administrative Committee of Sanshui Industrial Park, Foshan, Guangdong

Publicity Department of CPC of Foshan Sanshui District, China

Kaichuang Investment Co., Ltd., China

Guangzhou Gendustry Inc.

Foshan Sanshui New Energy Medical Devices Investment Co., Ltd

Gendustry Institute of South Medical University

South China Biochip Research Center
more...
© 2008 All right reserved for BIT Life Sciences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629